Pharma M&A and venture capital deals reach $33.7 billion in Jan 2025
Johnson & Johnson, Eli Lilly, and Gilead Sciences lead M&A activity; Venture capital investments increase by 62.1 per cent…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.